This dashboard provides a concise overview of SSV-EMS Data Systems for September 2025, covering ground and air medical services, clinical performance, and key operational indicators. It highlights patient impressions, response times, transport outcomes, medication usage, airway management, and compliance metrics to offer essential insights into service delivery.
Total ALS Responses
12,163
ALS Responses with ALS Medications
22.8%
ALS Responses with ALS Procedures
59.8%
ALS Responses with Any ALS Care
60.9%
7
Median Response Time
15
Median Scene Time
12
Median Transport Time
24
Median Time at Hospital
59
Median Total Time Committed
Total HEMS Patients
68
HEMS Responses with Any Procedures
4.4%
HEMS Responses With Any Medications
11.8%
HEMS Responses with Any Critical Care
11.8%
25
Median Response Time
17
Median Transport Time
27
Median Time at Hospital
108
Median Total Time Committed
1
Median Call Processing Time
Code-2 Response / Code-2 Transport
401
Code-2 Response / Code-3 Transport
9
Code-3 Response / Code-2 Transport
11
Code-3 Response / Code-3 Transport
4
| Medication | Patients | Doses |
|---|---|---|
| Ondansetron (Zofran) | 1013 | 1223 |
| Acetaminophen | 670 | 696 |
| Sodium chloride 9mg/ml | 595 | 686 |
| Aspirin (ASA) | 486 | 509 |
| Fentanyl | 461 | 817 |
| Nitroglycerin | 388 | 574 |
| Albuterol | 252 | 284 |
| Ipratropium | 228 | 242 |
| APAP 1000 MG per 100 ML Injectable Solution | 189 | 203 |
| Midazolam | 137 | 169 |
Median Change in Pain Scale
-3
Median Patient Age
65
| Medication | Over-Dosing | Under-Dosing | Within Range | Total |
|---|---|---|---|---|
| Acetaminophen | 6 | 10 | 9 | 25 |
| Activated Charcoal | 2 | |||
| Albuterol | 4 | |||
| Albuterol / Ipratropium | 2 | 2 | 4 | |
| Diphenhydramine | 2 | 8 | 10 | |
| Epinepherine 1:1000 | 4 | 4 | ||
| Epinephrine 1:10,000 | 1 | 7 | 8 | |
| Fentanyl | 1 | 15 | 28 | 44 |
| Glucose | 1 | 1 | ||
| Ipratropium | 4 | 4 | ||
| Ketamine | 1 | 1 | 2 |
| Primary Impression | Count |
|---|---|
| Traumatic Injury | 1885 |
| Non-Traumatic Body Pain | 1208 |
| General Weakness | 1154 |
| Abdominal Pain/Problems (GI/GU) | 879 |
| Pain/Swelling - Extremity - non-traumatic | 643 |
| ALOC - (Not Hypoglycemia or Seizure) | 634 |
| Behavioral/Psychiatric Crisis | 621 |
| Respiratory Distress/Other | 585 |
| Not Recorded | 577 |
| No Medical Complaint | 534 |
| Successful Attempts | 1st pass | 2nd Pass | Not Documented | Total |
|---|---|---|---|---|
| Supraglottic airway | 33 | 33 | ||
| Oral Intubation (With Video) | 12 | 1 | 1 | 14 |
| Oral Intubation (Without Video) | 7 | 3 | 10 |
Oral Intubation (With Video) First Pass Success
63%
Oral Intubation (Without Video) First Pass Success
64%
Supraglottic Airway First Pass Success
94%
Needle Cricothyrotomy First Pass Success
No Attempts
(Goal: 90%)
15%(Goal: 100%)
10.3%(Goal: 100%)
71.4%Stroke Patient Median Transport Time
16
| Incident County | Female | Male | Total |
|---|---|---|---|
| Butte | 4 | 13 | 17 |
| Nevada | 3 | 3 | 6 |
| Placer | 4 | 5 | 9 |
| Shasta | 6 | 12 | 18 |
| Siskiyou | 1 | 1 | 2 |
| Sutter | 7 | 9 | 16 |
| Tehama | 1 | 3 | 4 |
| Yuba | 2 | 5 | 7 |
| Total | 30 | 37 | 67 |
Naloxone Average Dose
2.81